Concepedia

C. Montagut Viladot

CM

Statistics

Publications

4

Citations

101

H-Index

4

Active since

2019

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Vall d'Hebron Institute of Oncology

Institut Català d'Oncologia

University of Perugia

C. Montagut Viladot is an author at Vall d'Hebron Hospital Universitari specializing in oncology, cetuximab therapy, and colorectal cancer.

Publications per year

2019–2025

4

Publications

4

LBA28 The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients

Sara Lonardi, Filippo Pietrantonio, N. Tarazona Llavero et al. · Annals of Oncology · 2023 · 58 citations · Full text

Medicine, Oncology, Surgery +16

Updated results of the BEACON CRC safety lead-in: Encorafenib (ENCO) + binimetinib (BINI) + cetuximab (CETUX) for BRAFV600E-mutant metastatic colorectal cancer (mCRC).

Scott Kopetz, Axel Grothey, Rona Yaeger et al. · Journal of Clinical Oncology · 2019 · 17 citations

Medicine, Oncology, Pharmacology +13

511MO Third line rechallenge with cetuximab (Cet) and irinotecan in circulating tumor DNA (ctDNA) selected metastatic colorectal cancer (mCRC) patients: The randomized phase II CITRIC trial

C. Santos Vivas, J. Vidal Barrull, C. Fernandez Rodriguez et al. · Annals of Oncology · 2024 · 16 citations · Full text

Medicine, Oncology, Pharmacology +15

723O Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients: Final results of the PEGASUS trial

S. Marsoni, Michele Prisciandaro, N. Tarazona Llavero et al. · Annals of Oncology · 2025 · 10 citations

Medicine, Oncology, Surgery +14

1–4 of 4